Endo USA, Inc. recalls

All Endo USA, Inc. recalls we track from FDA, CPSC and NHTSA data. Categories: drugs (11).

11 recalls published between January 15, 2025 and May 20, 2026. 5 were FDA Class I, the most serious level.

• Buprenorphine Hydrochloride, Injection, 0.3mg/mL… recall
  FDA May 20, 2026 · Endo USA, Inc. · Class II
• Everolimus tablets 2.5 mg, 28 tablets (each carton contains 4 blister… recall
  FDA November 5, 2025 · Endo USA, Inc. · Class III
• Everolimus tablets 10 mg, 28 tablets (each carton contains 4 blister… recall
  FDA November 5, 2025 · Endo USA, Inc. · Class III
• Everolimus tablets 7.5mg, 28 tablets (each carton contains 4 blister… recall
  FDA November 5, 2025 · Endo USA, Inc. · Class III
• Everolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips… recall
  FDA November 5, 2025 · Endo USA, Inc. · Class III
• Everolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips… recall
  FDA October 22, 2025 · Endo USA, Inc. · Class III
• Adrenalin Chloride Solution (Epinephrine Nasal Solution, USP)… recall
  FDA February 12, 2025 · Endo USA, Inc. · Class I
• Clonazepam Orally Disintegrating Tablets, USP, 1 mg, C-IV, Rx Only… recall
  FDA January 15, 2025 · Endo USA, Inc. · Class I
• Clonazepam Orally Disintegrating Tablets, USP, 0.25 mg, C-IV, Rx Only… recall
  FDA January 15, 2025 · Endo USA, Inc. · Class I
• Clonazepam Orally Disintegrating Tablets, USP, 0.125 mg, C-IV, Rx Only… recall
  FDA January 15, 2025 · Endo USA, Inc. · Class I
• Clonazepam Orally Disintegrating Tablet, USP, 2 mg, C-IV, Rx Only… recall
  FDA January 15, 2025 · Endo USA, Inc. · Class I